Skip to Content

C 431 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint C 431 is White, Round and has been identified as Darifenacin hydrobromide extended-release 7.5 mg. It is supplied by Cipla USA Inc..

Darifenacin is used in the treatment of overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 431

Darifenacin hydrobromide extended-release

C 431
7.5 mg
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cipla USA Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.